ArticleBMC neurology2020

Design of a non-interventional post-marketing study to assess the long-term safety and effectiveness of ocrelizumab in German real world multiple sclerosis cohorts - the CONFIDENCE study protocol.

Petra Dirks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.